High-dependency unit

The Surge in New Cases Reinforces the Importance of a Healthy Lifestyle

Retrieved on: 
Monday, August 9, 2021
HOLX, Headache, Privacy, US Foods, Editorial, US FDA, Hologic, Marketing, OTCQB, Contextual advertising, Coronavirus, Financial News, KGO-TV, Goal, NYS, COVID-19, CEO, World, World Health Organization's response to the COVID-19 pandemic, OTC, Delta, NASDAQ, Use, Infection, ABC7, Fever, Instagram, Disclosure, Twitter, Vaccine, Herbal, Vaccination, Panther, Smell, Therapy, Center, Social media, Time, Fatigue, International, News, University of California, San Francisco, Patient, Alchemy, CFS, Congestion, Centers for Disease Control and Prevention, Privacy policy, N, Policy, MNI - Market News, Company, United States patent law, University, Severe acute respiratory syndrome coronavirus 2, Advertising, Bias, Research, CDC, Cough, High-dependency unit, Virus, Pharmaceutical industry, Public relations

NEW YORK, Aug. 9, 2021 /PRNewswire/ -- While most of the economy has reopened, the number of new cases is once again on the rise. This time, two variants of COVID-19, the delta and lambda variants, are causing the numbers of newly inflected to rise. Delta is the most recent of four coronavirus mutations added to the World Health Organization's and Centers for Disease Control and Prevention's "variants of concern" lists. "[Delta is] mutating compared to other viruses incredibly quickly. I think a big part of that is because there is a significant percentage of people who are getting infected and are asymptomatic," Dr. Nevan Krogan, a University of California San Francisco, told KGO-TV according to ABC7. "The world is really a huge petri dish." Todos Medical Ltd. (OTC: TOMDF), Agenus Inc. (NASDAQ: AGEN), Hologic, Inc. (NASDAQ: HOLX), VBI Vaccines Inc. (NASDAQ: VBIV), iBio, Inc. (NYS: IBIO)

Key Points: 
  • This time, two variants of COVID-19, the delta and lambda variants, are causing the numbers of newly inflected to rise.
  • Even though vaccines are available and are being rolled out, testing remains a crucial factor.
  • In addition, to reduce the severity of symptoms from the virus, a healthy immune system is the key.
  • This USPTO notice of allowance underscores the desire in the marketplace for Tollovid, especially given its high dose, 5-day formulation that helps to support and maintain healthy immune function.

Statement from the Chief Public Health Officer of Canada on August 6, 2021

Retrieved on: 
Friday, August 6, 2021
COVID-19 vaccine, Public Health Agency of Canada, COVID, B.1.1.7, Public health, Literacy, Vaccination, Beta, Infection, Population, Vaccine, Risk assessment, COVID-19, Public Health Agency, PHAC, Life, Severe acute respiratory syndrome coronavirus 2, Death, Immunity, ICU, Profile, Transport, Government of Canada, Risk, Volatile organic compound, Euclidean distance, Anxiety, Hospital, High-dependency unit, VOC, Animal, Pharmaceutical industry

The Public Health Agency of Canada(PHAC) provides regular updates on COVID-19 vaccines administered , vaccination coverage and ongoing monitoring of vaccine safety across the country.

Key Points: 
  • The Public Health Agency of Canada(PHAC) provides regular updates on COVID-19 vaccines administered , vaccination coverage and ongoing monitoring of vaccine safety across the country.
  • Hence, as public health restrictions are eased across the country, we are closely monitoring increases in disease activity, particularly among unvaccinated populations.
  • The Government of Canada, via the Immunization Partnership Fund , supports initiatives to improve access to vaccines and encourage vaccine uptake.
  • By keeping the momentum up, Canada is within reach of having at least 80% of the eligible population fully vaccinated.

NRC Health Announces Winner of 2021 Excellence in Human Understanding Award

Retrieved on: 
Friday, August 6, 2021
Linda, National Research Corporation, Industry, Loma Linda, California, Empathy, NASDAQ, Patient, Human, Loma Linda University Medical Center, Family, Health, ICU, Nursing, EMS, Physician, Trust, Culture, Comprehension, High-dependency unit, GLOBE, Face, NRC, Medicine, Hospital

LINCOLN, Neb., Aug. 06, 2021 (GLOBE NEWSWIRE) -- NRC Health , the leading provider of in-depth customer insights in healthcare, today named Stephanie Schwarzenbach, Manager of ICU at Loma Linda University Medical Center Murietta , the winner of its second-annual Excellence in Human Understanding Award .

Key Points: 
  • LINCOLN, Neb., Aug. 06, 2021 (GLOBE NEWSWIRE) -- NRC Health , the leading provider of in-depth customer insights in healthcare, today named Stephanie Schwarzenbach, Manager of ICU at Loma Linda University Medical Center Murietta , the winner of its second-annual Excellence in Human Understanding Award .
  • The Excellence in Human Understanding Award was created in 2020 to honor individuals that have a complete comprehension of a customer's preferences, needs, and behaviorsresulting in overall improved care experiences.
  • This award recognizes Schwarzenbach for her distinctive contributions to healthcare, entrenching Human Understanding in the Loma Linda UMC health community.
  • Schwarzenbach inspired her team to act with Human Understanding by leading with empathy and compassion in times of health crisis.

Researchers from Hackensack Meridian University Medical Center and Colleagues Develop New Model to Help Clinicians Predict Risk of Death in Patients Hospitalized with COVID-19

Retrieved on: 
Thursday, August 5, 2021
Well, Hackensack Meridian School of Medicine, Use-centered design, Research, Hackensack Meridian Health, High-dependency unit, Man, Hackensack University Medical Center, Division, Coronavirus, Coronary artery disease, Risk, Mortality, COVID-19, Patient, Limited liability company, PLOS One, Associate, Therapy, PLOS, Severe acute respiratory syndrome coronavirus 2, Degenerative disease, Respiratory rate, COVID-19 deaths, FACS, Health information management, Nursing, Chronic kidney disease, Doctor of Philosophy, Death, Hospital, Vaccination, Pharmaceutical industry

HACKENSACK, N.J., Aug. 5, 2021 /PRNewswire/ -- Researchers from Hackensack Meridian University Medical Center and Berry Consultants, LLC, Austin, Texas have developed a new model to help clinicians predict the risk of death within 40 days in patients who are hospitalized with COVID-19 infection.

Key Points: 
  • HACKENSACK, N.J., Aug. 5, 2021 /PRNewswire/ -- Researchers from Hackensack Meridian University Medical Center and Berry Consultants, LLC, Austin, Texas have developed a new model to help clinicians predict the risk of death within 40 days in patients who are hospitalized with COVID-19 infection.
  • "It's significant that severe COVID-19 disease has occurred principally among individuals with pre-existing comorbid conditions, said Andrew Ip, MD, Division of Outcomes and Value Research, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack NJ.
  • Patients with comorbidities are more likely to require hospitalization and intensive care support compared to individuals without additional risk factors.
  • Hackensack University Medical Center's comprehensive clinical research portfolio includes studies focused on precision medicine, translational medicine, immunotherapy, cell therapy, and vaccine development.

Hospital Acquired Infection Control Market Analysis Report 2021-2028 by Type (Equipment, Services, Consumables), by End User (Hospitals & ICUs, Ambulatory Surgical & Diagnostic Centers) - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 4, 2021
Infectious Diseases, Hospitals, Health, Health, Medical specialties, Infectious diseases, Epidemiology, Occupational safety and health, Healthcare-associated infections, Hospital-acquired infection, COVID-19, Infection prevention and control, Infection, Surgery

The "Hospital Acquired Infection Control Market Size, Share & Trends Analysis Report by Type (Equipment, Services, Consumables), by End User (Hospitals & ICUs, Ambulatory Surgical & Diagnostic Centers), by Region and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hospital Acquired Infection Control Market Size, Share & Trends Analysis Report by Type (Equipment, Services, Consumables), by End User (Hospitals & ICUs, Ambulatory Surgical & Diagnostic Centers), by Region and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.
  • The key factors driving the market growth include the rising incidence of Hospital Acquired Infections (HAIs), supportive government initiatives and the COVID-19 pandemic.
  • The demand for infection control equipment and consumables also stemmed from the need to stop the spread of COVID-19.
  • The company was merged into Getinge's Infection Control portfolio to expand its offerings in the business area of Surgical Workflows
    Chapter 3 Hospital Acquired Infection Control Market Variables, Trends & Scope